Latest News

Conference Image

2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®

The in-person annual Transplantation & Cellular Therapy Meetings of ASTCT™ (American Society for Transplantation and Cellular Therapy) and CIBMTR® (Center for International Blood and Marrow Transplant Research) took place from February 15-19, 2023 in Orla

Female reproductive organs
Late Breaking News

Two Trials to Change the Landscape for First-Line Treatment for Advanced or Recurrent Endometrial Cancer

The use of molecular classification within endometrial cancer has continued to evolve with the incorporation of biomarker-driven therapy .


Professional Cancer Associations Collaborate to Improve Treatment of Anemia in Adult Patients with Myelodysplastic Syndromes

The initiative will provide support and guidance to community hematologists/oncologists on the risk-stratification of MDS, selection of evidence-based and novel therapies for the management of anemia in patients with lower-risk MDS, and on best practices


Oncology Experts Join Together to Provide Best Possible Care for Adolescents and Young Adults with Cancer

The Hematology/Oncology Pharmacy Association (HOPA) has partnered with Stupid Cancer, the leader in young adult cancer advocacy, research, and support, to develop tools for healthcare providers who serve the adolescent and young adult (AYA) patient commun

Late Breaking News Tools and Resources

Immune Checkpoint Inhibitors Make Great Strides in Hepatocellular Carcinoma

STRIDE presents an alternative first-line choice for patients with unresectable HCC with a manageable side effect profile and a 22% reduction in risk of death over sorafenib

Pharmacists at work

Reflections from a Life-long Oncology Pharmacist: “Unconditional Care”

Siu Fun Wong, PharmD, FASHP, FCSHP Clinical Professor (Volunteer) Division of Hematology/Oncology, Department of Medicine UCI Health, Orange, CA

Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey

The survey was developed by the HOPA Practice Outcomes and Professional Benchmarking Committee (POPBC) and distributed between March 2021 and January 2022

colonoscopy image
Late Breaking News

Is Colonoscopy Here to Stay? Evaluation of Average Risk Colorectal Cancer Screening Updates & Review of NordICC

Colorectal cancer (CRC) is the fourth most common cancer diagnosed in the United States (US) and second leading cause of cancer death in the US and worldwide.1

Pharmacist's Application to Practice: Retifanlimab-dlwr

Bernard Marini, PharmD, BCOP, Clinical Pharmacist Specialist at University of Michigan College of Pharmacy writes about Retifanlimab-dlwr.

Tools and Resources

Pharmacist’s Applications to Practice: Elacestrant

Monica Chintapenta, PharmD, BCOP, Pharmacist Clinical Specialist at Parkland Health and Hospital Systems writes about Elacestrant

Tools and Resources

Pharmacist's Application to Practice: Pirtobrutinib

Andy Hawn, 2025 PharmD Candidate and Erin Kelley, PharmD, BCOP at the Masonic Cancer Clinic Infusion Pharmacy write about Pirtobrutinib

Tools and Resources Late Breaking News

BPS Announces Professional Development Programs Approved for the Recertification of Board-Certified Pharmacists beginning in January 2024

BPS Announces Professional Development Programs Approved for the Recertification of Board-Certified Pharmacists beginning in January 2024